Market Research Logo

Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021

Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021

About Anti-Nuclear Antibody (ANA) Testing

Antibodies that attack healthy proteins in the nucleus cells are called antinuclear antibodies. When a person has an autoimmune disease such as rheumatoid arthritis or systemic lupus erythematosus (SLE), the immune system produces antibodies that will attach to the cells, often causing damage to them. Some of the ANA tests are EUROPLUS ANA Mosaic 20A, QUANTA Lite ANA, BioPlex 2200 ANA Screen. The global ANA testing market is expected to benefit from the growing incidence of several autoimmune diseases worldwide.

Technavio’s analysts forecast the global anti-nuclear antibody (ANA) testing market to grow at a CAGR of 7.13 % during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global anti-nuclear antibody (ANA) testing market for 2017-2021. To calculate the market size, the report considers the new installations/sales/volume/value and replacement/ services of anti-nuclear antibody testing market.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Anti-Nuclear Antibody (ANA) Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • Alere
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
Other prominent vendors
  • Antibodies Incorporated
  • Biocom Biotech
  • Erba Diagnostics
  • F. Hoffmann-La Roche
  • HOB Diagnostics
  • HUMAN Diagnostics
  • IMMCO
  • ImmunArray
  • Phadia
  • Seramun Diagnostica
  • Trinity Biotech
Market driver
  • Increased prevalence of autoimmune diseases
  • For a full, detailed list, view our report
Market challenge
  • Limitations of autoimmune disease diagnostics
  • For a full, detailed list, view our report
Market trend
  • Shift from monoplex to multiplex testing
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Anti-Nuclear Antibody (ANA) Testing Market 2017-2021
Technavio recognizes the following companies as the key players in the global anti-nuclear antibody (ANA) testing market: Abbott Laboratories, Alere, Bio-Rad Laboratories, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Antibodies Incorporated, Biocom Biotech, Erba Diagnostics, F. Hoffmann-La Roche, HOB Diagnostics, HUMAN Diagnostics, IMMCO, ImmunArray, Phadia, Seramun Diagnostica, and Trinity Biotech.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is shift from monoplex to multiplex testing. The focus on multiplex testing is increasing, particularly in the area of IVD, owing to the increased need for effective diagnosis. Autoimmune diseases are chronic conditions that collectively affect around 5% to 8% of the US population. The individuals who develop organ-specific autoimmune disease have a high likelihood of developing additional autoimmune disorders. This has fueled the need for new technologies that can evaluate multiple immune reactivities in a small sample volume.”
According to the report, one of the major drivers for this market is increased prevalence of autoimmune diseases. Autoimmune diseases can affect any organ or system in the body, with the symptoms varying among disease types. There are about 80 types of autoimmune diseases in the world. Rheumatoid arthritis, Lupus, Celiac disease, and multiple sclerosis are some of the autoimmune diseases.

Further, the report states that one of the major factors hindering the growth of this market is limitations of autoimmune disease diagnostics. The limitations of autoimmune disease diagnostics in terms of key parameters such as accuracy pose a challenge to the market. The accuracy of autoimmune disease diagnostics determines the quality of results. Any discrepancy in this parameter will be unproductive to end-users, thereby impacting adoption rates. There are only a few tests that can potentially offer quality results. These tests allow rapid decision making and administration of suitable therapies for treating individuals with autoimmune diseases.

Companies Mentioned

Abbott Laboratories, Alere, Bio-Rad Laboratories, Thermo Fisher Scientific, Antibodies Incorporated, Biocom Biotech, Erba Diagnostics, F. Hoffmann-La Roche, HOB Diagnostics, HUMAN Diagnostics, IMMCO, ImmunArray, Phadia, Seramun Diagnostica, and Trinity Biotech.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Etiology of autoimmune diseases
      • Table Global ANA testing market 2016-2021: Market outline
  • Market landscape
    • Market overview
      • Table Key trends in global autoimmune disease diagnostics market: Impact assessment
    • Market size and forecast
      • Table Global ANA testing market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by end-user
    • Table Global ANA testing market by end-users: Overview
    • Hospitals
    • Clinical diagnostic laboratories
      • Table Global ANA testing market by end-users: Impact assessment
  • Geographical segmentation
    • Table Global ANA testing market by geography 2016 (%)
    • ANA testing market in Americas
      • Table ANA testing market in Americas 2016-2021: Overview
      • Table ANA testing market in Americas 2016-2021 ($ millions)
    • ANA testing market in EMEA
      • Table ANA testing market in EMEA 2016-2021: Overview
      • Table ANA testing market in EMEA 2016-2021 ($ millions)
    • ANA testing market in APAC
      • Table ANA testing market in APAC 2016-2021: Overview
      • Table ANA testing market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Incidence estimates of type 1 diabetes, children aged 0-14 years, 2014
      • Table Key initiatives of vendors fueling the launch of novel biomarkers
    • Market challenges
  • Market trends
    • Shift from monoplex to multiplex testing
    • Collaborations between pharma and diagnostic companies
    • Growing consumer shift toward direct-toconsumer testing
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global ANA testing market 2016
      • Table Competitive landscape analysis of global ANA testing market 2016
      • Table Strategic success factors of companies in global ANA testing market
  • Key vendor analysis
    • Abbott Laboratories
      • Table Abbott Laboratories: Key highlights
      • Table Abbott Laboratories: Strength assessment
      • Table Abbott Laboratories: Strategy assessment
      • Table Abbott Laboratories: Opportunity assessment
    • Alere
      • Table Alere: Key highlights
      • Table Alere: Strength assessment
      • Table Alere: Strategy assessment
      • Table Alere: Opportunity assessment
    • Bio-Rad Laboratories
      • Table Bio-Rad Laboratories: Key highlights
      • Table Bio-Rad Laboratories: Strength assessment
      • Table Bio-Rad Laboratories: Strategy assessment
      • Table Bio-Rad Laboratories: Opportunity assessment
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific: Key highlights
      • Table Thermo Fisher Scientific: Strategy assessment
      • Table Thermo Fisher Scientific: Strategy assessment
      • Table Thermo Fisher Scientific: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report